Michael L. Levitz - 10 Aug 2022 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role: EVP, CFO, Treasurer
Signature: /s/ Michael L. Levitz
Issuer symbol: ANIK
Transactions as of: 10 Aug 2022
Net transactions value: $0
Form type: 4
Filing time: 11 Aug 2022, 16:11:49 UTC
Previous filing: 14 Mar 2022
Next filing: 10 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANIK	Common Stock	Options Exercise	$0	+3,859	+23%	$0.000000	20,423	10 Aug 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANIK	Restricted Stock Unit	Options Exercise	$0	-3,859	-50%	$0.000000	3,859	10 Aug 2022	Common Stock	3,859	$0.000000	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on August 10, 2020. The 3,859 shares resulting from the RSU vest were retained in full as a result of Mr. Levitz's election to pay cash to cover the applicable taxes resulting from the RSU vest.
F2	Includes 640 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 13, 2022.
F3	Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning August 10, 2021.